No Data
Advancing the IT modernization of Mainland Education with "NEXTGIGA".
The "GIGA School Concept," which aims to digitalize the education sector, has entered a new phase. In the first phase, which started in 2019, the infrastructure for PCs and tablets, along with networking, has progressed, but in the next phase called "NEXTGIGA," updates for devices and performance enhancements will be implemented. There is a renewed focus on related stocks. <The demand for device updates is intensifying> In the first phase of the GIGA School, one PC or tablet is provided for each student in elementary, middle, and high schools nationwide.
Solvvy---The results of the clinical research with Chiba Universities School of Medicine Hospital have been published in "Scientific Reports."
On the 22nd, Solvvy <7320> announced that the results of a clinical study conducted by the Pain Center of the Chiba University Hospital, utilizing the Neuro Switch app developed by its research and development division, Solvvy LAB., were published in the academic journal "Scientific Reports" issued by the Nature Portfolio. This research serves as a new biomarker for predicting the effectiveness of cognitive behavioral therapy (CBT) for patients with chronic lower back pain.
Company Research Report: Solvvy Inc. (7320)
Solvvy--- "Neuro Switch for Wellness" has started selling.
On the 1st, Solvvy <7320> announced that its subsidiary Broadcasting Seek has started selling a brain training Commodity ETF called "Neuro Switch for Wellness," aimed at preventing dementia, alleviating physical pain, and reducing stress. The product consists of a brain wave measurement device and a neurofeedback practice guidebook, and includes a one-year product warranty from the date of purchase. Moreover, there are effects demonstrated in medical papers regarding the improvement of short-term memory and the relief of chronic pain.
Solvvy—official establishment of the cutting-edge technology research institute "Solvvy LAB."
On the 11th, Solvvy <7320> officially announced the establishment of its advanced technology research institution, "Solvvy LAB." The company has previously collaborated with the Hospital Pain Center of the University of Tokyo and the Hospital affiliated with Chiba University, focusing on research related to brain waves (neurofeedback) through its subsidiary, MediaSeek, and has utilized the results in product development. Additionally, in February 2025, a guarantee service utilizing AI diagnostic technology for onboard Batteries of EVs will be launched.
Solvvy: Extraordinary Report
